Xinermei, launched in July, is the third once-weekly injectable GLP-1 weight management therapy available in China after Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro. Those were introduced in late 2024 and January 2025 respectively, several months after their own approvals, into a Chinese weight-loss drug market that is expected by analysts to be worth billions […]

Two weeks back, Audemars Piguet was quick to shut down a report suggesting chief executive Ilaria Resta was leaving the company. She would be going nowhere, the family-owned Swiss watchmaker said. In the days following, Resta was in Hong Kong unveiling a new collection of watches as part of Audemars Piguet’s 150th anniversary celebrations, where […]

On Tuesday, London-based lab-grown diamond brand Astrea named Sarah Jessica Parker as its global creative director. The “Sex and the City” star has also invested in the brand. In the role, Parker will work with Astrea’s design team to create pieces for the brand — the first include a pair of chandelier earrings, a moi-and-toi […]

Indonesia and the European Union have reached a major free trade agreement after nine long years of talks. The deal was signed on September 23, 2025, in Nusa Dua on Bali island. Both sides hope it will help boost their economies and protect against new tariffs from US President Donald Trump. The agreement, called the […]

Pfizer, the US drugmaker, agreed to buy Metsera for $47.50 in cash per share, and further payments of up to $22.50 per share if three specific and regulatory milestones are met, it said Monday, with a total potential value of $7.3 billion. The deal represents a 43 percent premium to Metsera’s closing share price on […]